14297-28-0

Basic information

• Product Name: [4-[[[2-(5-aminotetrazol-1-yl)acetyl]hydrazinylidene]methyl]-2-methoxy-phenyl] 2-chloro-4,5-difluoro-benzoate
• Synonyms: [4-[[[2-(5-aminotetrazol-1-yl)acetyl]hydrazinylidene]methyl]-2-methoxy-phenyl] 2-chloro-4,5-difluoro-benzoate
• CAS NO: 14297-28-0
• Molecular Formula: C₁₈H₁₄ClF₂N₇O₄
• Molecular Weight: 174.2
• Mol File: 14297-28-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: [4-[[[2-(5-aminotetrazol-1-yl)acetyl]hydrazinylidene]methyl]-2-methoxy-phenyl] 2-chloro-4,5-difluoro-benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: [4-[[[2-(5-aminotetrazol-1-yl)acetyl]hydrazinylidene]methyl]-2-methoxy-phenyl] 2-chloro-4,5-difluoro-benzoate(14297-28-0)
• EPA Substance Registry System: [4-[[[2-(5-aminotetrazol-1-yl)acetyl]hydrazinylidene]methyl]-2-methoxy-phenyl] 2-chloro-4,5-difluoro-benzoate(14297-28-0)

Safety Data

• Hazardous Substances Data: 14297-28-0(Hazardous Substances Data)

Usage

Description

[4-[[[2-(5-aminotetrazol-1-yl)acetyl]hydrazinylidene]methyl]-2-methoxy-phenyl] 2-chloro-4,5-difluoro-benzoate is a complex organic compound characterized by its diverse functional groups and molecular structure. It features a phenyl ring with a methoxy group, a 2-chloro-4,5-difluoro-benzoate moiety, and a hydrazinylidene-methyl group attached to a 5-aminotetrazol-1-yl and an acetyl group. This intricate arrangement of atoms and bonds suggests potential applications in various fields, including pharmaceuticals, agrochemicals, and material science. Further investigation into its properties and reactivity is necessary to fully comprehend its potential uses and effects.

Uses

Used in Pharmaceutical Applications:
[4-[[[2-(5-aminotetrazol-1-yl)acetyl]hydrazinylidene]methyl]-2-methoxy-phenyl] 2-chloro-4,5-difluoro-benzoate is used as a pharmaceutical compound for its potential therapeutic properties. [4-[[[2-(5-aminotetrazol-1-yl)acetyl]hydrazinylidene]methyl]-2-methoxy-phenyl] 2-chloro-4,5-difluoro-benzoate's unique structure may allow it to interact with biological targets, such as receptors or enzymes, in ways that could lead to the development of new drugs for various diseases.
Used in Agrochemical Applications:
In the agrochemical industry, [4-[[[2-(5-aminotetrazol-1-yl)acetyl]hydrazinylidene]methyl]-2-methoxy-phenyl] 2-chloro-4,5-difluoro-benzoate is used as a chemical intermediate for the synthesis of various agrochemical products. Its reactivity and functional groups may be harnessed to create new pesticides, herbicides, or other agricultural chemicals that can improve crop yields and protect plants from pests.
Used in Material Science Applications:
[4-[[[2-(5-aminotetrazol-1-yl)acetyl]hydrazinylidene]methyl]-2-methoxy-phenyl] 2-chloro-4,5-difluoro-benzoate is used as a building block in the development of new materials with specific properties. Its molecular structure may contribute to the creation of advanced materials for various applications, such as electronics, coatings, or polymers, by providing unique chemical and physical characteristics.

Upstream product

• 6940-46-1 N-(α-bromo-isovaleryl)-glycine 
• 1149-26-4 N-benzyloxycarbonylvaline 
• 7801-65-2 N-(N-benzyloxycarbonyl-DL-valyl)-glycine ethyl ester 
• 2816-12-8 4-isopropyl-2,5-oxazolidinedione 
• 516-06-3 D,L-valine 
• 7664-41-7 ammonia 
• 85864-65-9 [(S)-2-(2-{(S)-2-[2-((S)-2-Amino-3-phenyl-propionylamino)-acetylamino]-4-methyl-pentanoylamino}-acetylamino)-3-methyl-butyrylamino]-acetic acid 
• 40331-73-5 4-isopropyl-3-(2-nitro-phenylsulfanyl)-oxazolidine-2,5-dione 
• 56-40-6 glycine 
• 74088-26-9 N-(N-benzyloxycarbonyl-DL-valyl)-glycine 
• 27109-47-3 2-bromoisovaleryl chloride 
• 10323-40-7 2-bromoisovaleric acid 

Downstream Products

• 16944-60-8 3-isopropyl-piperazine-2,5-dione 
• 95753-63-2 DL-5-isopropyl-3-<4-<(2S)-Fmocamino-2-methoxycarbonylethyl>phenyl>-2-thiohydantoin 
• 78-82-0 Isobutyronitrile 
• 56-40-6 glycine 
• 640-68-6 D-Val-OH 
• 69288-25-1 alanyl=>valyl=>glycine 

Relevant articles and documents

METHOD FOR PRODUCING GAMMA -GLUTAMYL-VALYL-GLYCINE CRYSTAL

The present invention provides a method for efficiently producing a γ-glutamyl-valyl-glycine crystal. Specifically, the present invention provides a method for producing a γ-glutamyl-valyl-glycine crystal, which includes the steps of: preparing a mixed solution of valyl-glycine or a salt thereof and γ-glutamyl-valyl-glycine, wherein the mixed solution contains valyl-glycine or the salt thereof in an amount of 20 mass % or more relative to the mass of γ-glutamyl-valyl-glycine; adjusting the amount of valyl-glycine or the salt thereof in the prepared mixed solution to 0.1 mass % or more and less than 20 mass % relative to the mass of γ-glutamyl-valyl-glycine to prepare a γ-glutamyl-valyl-glycine solution; and subjecting the γ-glutamyl-valyl-glycine solution to a crystallization procedure to produce the γ-glutamyl-valyl-glycine crystal.

19 F nuclear magnetic resonance for the control of peptide synthesis.

-